
Sign up to save your podcasts
Or


A conversation with Dr. Ira Casson (who served on the National Football League’s committee on mild traumatic brain injury and co-authored several of its studies on MTBI) reveals that it may be impossible to assess the value of its six-season study. Despite the author’s defense of the methods used to conduct the research, there’s room for skepticism, both in the light of a New York Times story reporting that over 10% of such injuries may have gone unreported and the study’s assumption that all teams reported all injuries.
We asked the League to make the studies’ first author available for this conversation, and they declined.
By NEJM Group4.5
5656 ratings
A conversation with Dr. Ira Casson (who served on the National Football League’s committee on mild traumatic brain injury and co-authored several of its studies on MTBI) reveals that it may be impossible to assess the value of its six-season study. Despite the author’s defense of the methods used to conduct the research, there’s room for skepticism, both in the light of a New York Times story reporting that over 10% of such injuries may have gone unreported and the study’s assumption that all teams reported all injuries.
We asked the League to make the studies’ first author available for this conversation, and they declined.

7,639 Listeners

319 Listeners

2,055 Listeners

126 Listeners

506 Listeners

298 Listeners

895 Listeners

265 Listeners

3,360 Listeners

111,948 Listeners

90 Listeners

5 Listeners

93 Listeners

517 Listeners

2,534 Listeners

373 Listeners

15,950 Listeners

58 Listeners

40 Listeners

59 Listeners